HSIC
56
5
APD
59
2
SYY
53
4
DD
63
3
SNA
68
-2
CHRW
56
-3
CMA
61
5
CSX
60
3
AIV
72
2
HPE
63
2
JWN
48
6
SLB
55
2
ES
34
3
BSX
67
-3
EMN
60
4
AMG
54
2
TJX
64
2
URBN
56
14
RL
72
4
KLAC
47
4
HSIC
56
5
APD
59
2
SYY
53
4
DD
63
3
SNA
68
-2
CHRW
56
-3
CMA
61
5
CSX
60
3
AIV
72
2
HPE
63
2
JWN
48
6
SLB
55
2
ES
34
3
BSX
67
-3
EMN
60
4
AMG
54
2
TJX
64
2
URBN
56
14
RL
72
4
KLAC
47
4
Financhill
Back

Sonoma Pharmaceuticals 10K Form

Sell
15

SNOA
Sonoma Pharmaceuticals

Last Price:
2.89
Seasonality Move:
9.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SNOA News And Ratings

See the #1 stock for the next 7 days that we like better than SNOA

SNOA Financial Statistics

Sales & Book Value

Annual Sales: $12.74M
Cash Flow: $328K
Price / Cash Flow: 0
Annual Sales: $4.00
Price / Book: 0.71

Profitability

EPS (TTM): -4.95730
Net Income (TTM): $-3.69M
Gross Margin: $4.75M
Return on Equity: -63.92%
Return on Assets: -26.2%

Sonoma Pharmaceuticals Earnings Forecast

Key Sonoma Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 23 years for SNOA is 37.26%.
  • The Selling, General & Administrative Expenses for SNOA have been equal to 59.48% of Gross Profit Margin.
  • The Research & Development expenses have been 14.69% of Revenue.
  • The Interest Expense is -0.25% of Operating Income.
  • The Net Earning history of SNOA is -37.97% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 16 years.

Sonoma Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SNOA
CUSIP: 83558L
Website: sonomapharma.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 3.69
Quick Ratio: 2.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SNOA Technical Analysis vs Fundamental Analysis

Sell
15
Sonoma Pharmaceuticals (SNOA) is a Sell

Is Sonoma Pharmaceuticals a Buy or a Sell?